Aquaporin expression promoter and keratinization marker expression promoter
Trilinolein from soybean milk fermented with lactic acid bacteria promotes the expression of aquaporins and keratinization markers, addressing the inefficacy and safety issues of conventional promoters, thereby enhancing skin moisture and defense functions.
Patent Information
- Application Number
- JP2020021579
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-06-12
- Filing Date
- 2020-02-12
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-02-12
AI Technical Summary
Conventional aquaporin and filaggrin expression promoters exhibit insufficient effects and safety concerns.
Aqueous solutions containing trilinolein, a product of soybean milk fermented with lactic acid bacteria, are used to promote the expression of aquaporins and keratinization markers such as aquaporin 1, aquaporin 3, aquaporin 4, aquaporin 5, aquaporin 6, aquaporin 8, aquaporin 9, aquaporin 10, aquaporin 11, filaggrin, involucrin, loricrin, transglutaminase, and keratin.
The solution effectively enhances the expression of aquaporins and keratinization markers, improving skin moisture retention and defense functions.
Smart Images

Figure 0007591756000003 
Figure 0007591756000004 
Figure 0007591756000005
Abstract
Description
[Technical field]
[0001] The present invention relates to an aquaporin expression promoter and a cornification marker expression promoter. [Background technology]
[0002] The epidermis is the outermost layer of the skin and acts as a barrier to prevent the intrusion of foreign substances from the outside and the evaporation of moisture from the body, protecting the inside. From the outside, the epidermis is structured as follows: stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale, and most of these layers are composed of keratinocytes. These keratinocytes are born every day in the basal layer, and are gradually pushed up by cells that divide and are born later, reaching the stratum corneum, where they change into keratinocytes. They then reach the outermost layer of the stratum corneum and gradually fall off naturally. The process from the birth to the fall of keratinocytes is called keratinization or turnover. It is extremely important for the normal function of the skin, that is, the skin's defense function, that this keratinization is carried out normally in the epidermis, and known keratinization markers include filaggrin, involucrin, loricrin, transglutaminase-1, transglutaminase-3, keratin-1, keratin-10, keratin-14, and keratin-20.
[0003] The epidermis also regulates the amount of water in the outside world and inside the body, and the water content of the keratinocytes inside is high. The moisture-retaining function of keratinocytes is regulated by the function of aquaporin molecules present in the cell membrane.
[0004] In addition, when the skin is damaged by ultraviolet rays, aging, environmental changes, etc., the skin's defense function and moisture retention function decline, and it is known that the decline in these functions is related to the decrease in the expression levels of keratinization markers and aquaporins in keratinocytes. Therefore, developing ingredients that promote the expression of keratinization markers and aquaporins is important in improving skin function.
[0005] Known aquaporin expression promoters include cryptoxanthin (Patent Document 1), various plant extracts (Patent Documents 2, 3, and 4), and phosphoserine (Patent Document 5). Known filaggrin expression promoters include Osmanthus fragrans extract (Patent Documents 6 and 7). [Prior art documents] [Patent documents]
[0006] [Patent Document 1] JP 2014-144960 A [Patent Document 2] JP 2013-87057 A [Patent Document 3] JP 2013-87058 A [Patent Document 4] JP 2013-95667 A [Patent Document 5] JP 2018-188413 A [Patent Document 6] JP 2009-256269 A [Patent Document 7] JP 2009-67749 A Summary of the Invention [Problem to be solved by the invention]
[0007] However, conventional aquaporin expression promoters and filaggrin expression promoters have problems such as insufficient effectiveness and safety concerns. Therefore, an object of the present invention is to provide a new technique for promoting the expression of aquaporins and keratinization markers. [Means for solving the problem]
[0008] Therefore, the present inventors conducted extensive research and found that trilinolein, a lactic acid bacteria fermentation product of soy milk, has excellent aquaporin expression promoting effects and excellent keratinization marker expression promoting effects, thereby completing the present invention.
[0009] That is, the present invention provides the following: <1> ~ <5> This provides: <1> An aquaporin expression promoter comprising one or more active ingredients selected from the following ingredients (A) and (B): (A) Soy milk fermented with lactic acid bacteria (B) Trilinolein <2> The aquaporin is one or more aquaporins selected from aquaporin 1, aquaporin 3, aquaporin 4, aquaporin 5, aquaporin 6, aquaporin 8, aquaporin 9, aquaporin 10, and aquaporin 11. <1> 2. An aquaporin expression promoter according to claim 1 . <3> The present invention comprises a lactic acid bacteria fermentation product of soy milk as an active ingredient, and the aquaporin is one or more kinds of aquaporins selected from aquaporin 4, aquaporin 5, aquaporin 6 and aquaporin 8. <1> 2. An aquaporin expression promoter according to claim 1 . <4> A keratinization marker expression promoter comprising one or more active ingredients selected from the following components (A) and (B): (A) Soy milk fermented with lactic acid bacteria (B) Trilinolein <5> The keratinization marker is one or more keratinization markers selected from filaggrin, involucrin, loricrin, transglutaminase, and keratin. <4> The cornification marker expression promoter according to claim 1. Effect of the Invention
[0010] The aquaporin expression promoter of the present invention has an excellent aquaporin expression promoting effect. The keratinization marker expression promoter of the present invention has an excellent effect of promoting the expression of keratinization markers. [Brief description of the drawings]
[0011] [Figure 1] FIG. 2 is a diagram showing the sequence of the culture process in Preparation Example 1. [Figure 2-1] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 1 in promoting aquaporin 1 expression. [Figure 2-2]FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 2 in promoting aquaporin 1 expression. [Figure 2-3] FIG. 1 shows the results of evaluating the effect of fraction 1 in promoting aquaporin 1 expression. [Figure 2-4] FIG. 1 shows the results of evaluating the effect of fraction 2 in promoting aquaporin 1 expression. [Figure 3-1] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 2 in promoting the expression of aquaporin 10. [Figure 3-2] FIG. 1 shows the results of evaluating the effect of fraction 1 in promoting the expression of aquaporin 10. [Figure 4-1] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 2 in promoting the expression of aquaporin 11. [Figure 4-2] FIG. 1 shows the results of evaluating the effect of fraction 1 in promoting the expression of aquaporin 11. [Figure 5-1] FIG. 1 shows the results of evaluating the effects of lactic acid bacteria production substance 1, fraction 1, and trilinolein on promoting aquaporin 1 expression. [Figure 5-2] A graph quantifying the evaluation results of the aquaporin 1 expression promoting effects of lactic acid bacteria production substance 1, fraction 1, and trilinolein. [Figure 5-3] FIG. 1 shows the results of evaluating the effects of lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, fraction 2, and trilinolein on promoting aquaporin 3 expression. [Figure 5-4] A graph quantifying the evaluation results of the aquaporin 3 expression promoting effects of lactic acid bacteria production substance 1, fraction 2, and trilinolein. [Figure 5-5] FIG. 1 shows the results of evaluating the effect of fraction 1 in promoting aquaporin 4 expression. [Figure 5-6] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 2 in promoting aquaporin 5 expression. [Figure 5-7] A graph quantifying the evaluation results of the effect of lactic acid bacteria production substance 2 in promoting aquaporin 5 expression. [Figure 5-8] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, and fraction 2 on promoting aquaporin 6 expression. [Figure 5-9]A graph quantifying the evaluation results of the effect of lactic acid bacteria production substance 1 and fraction 2 on promoting aquaporin 6 expression. [Figure 5-10] FIG. 1 shows the results of evaluating the effect of fraction 2 in promoting aquaporin 8 expression. [Figure 5-11] FIG. 1 shows the results of evaluating the effects of lactic acid bacteria production substance 1, fraction 1, fraction 2, and trilinolein on promoting aquaporin 9 expression. [Figure 5-12] A graph quantifying the evaluation results of the aquaporin 9 expression promoting effect of fraction 2, trilinolein. [Figure 5-13] FIG. 1 shows the results of evaluating the effects of lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, and trilinolein on promoting aquaporin 10 expression. [Figure 5-14] This figure quantifies the evaluation results of the aquaporin 10 expression promoting effect of lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, and trilinolein. [Figure 6-1] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 1 in promoting the expression of filaggrin, involucrin, and loricrin. [Figure 6-2] FIG. 1 shows the results of evaluating the transglutaminase and keratin expression promoting effect of lactic acid bacteria production substance 1. [Figure 7-1] FIG. 1 shows the results of evaluating the effect of lactic acid bacteria production substance 2 in promoting the expression of filaggrin, involucrin, and loricrin. [Figure 7-2] FIG. 1 shows the results of evaluating the transglutaminase expression promoting effect of lactic acid bacteria production substance 2. [Figure 8-1] FIG. 1 shows the results of evaluating the effect of fraction 1 in promoting the expression of filaggrin, involucrin, and loricrin. [Figure 8-2] FIG. 1 shows the results of evaluation of the transglutaminase and keratin expression promoting effect of fraction 1. [Figure 9-1] FIG. 1 shows the results of evaluating the effect of fraction 2 in promoting the expression of filaggrin, involucrin, and loricrin. [Figure 9-2] FIG. 1 shows the results of evaluating the transglutaminase and keratin expression promoting effects of fraction 2. [Figure 10-1]FIG. 1 shows the results of evaluating the effect of trilinolein in promoting the expression of filaggrin, involucrin, and loricrin. [Figure 10-2] FIG. 1 shows the results of evaluating the transglutaminase and keratin expression promoting effect of trilinolein. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] The aquaporin expression promoter and keratinization marker expression promoter of the present invention contain, as an active ingredient, one or more selected from the following components (A) and (B): (A) Soy milk fermented with lactic acid bacteria (B) Trilinolein
[0013] The trilinolein may be a commercially available product or may be synthesized by a known method. Next, the above-mentioned "lactic acid bacteria fermentation product of soy milk" will be described in detail. The lactic acid bacteria fermentation product of soy milk is a fermented product obtained by fermenting soy milk with lactic acid bacteria. The lactic acid bacteria fermentation product of soy milk may be in any of a liquid, semi-liquid, or solid form. The soy milk may be any soy milk that can be used as a food or a raw material thereof. For example, liquid or powdered soy milk such as unadjusted soy milk, adjusted soy milk, soy milk beverage, and dried powder of soy milk may be mentioned, and concentrated or diluted soy milk may be used. One of these may be used alone, or two or more may be used in combination. The soybean solid content concentration in the soy milk is preferably 1 to 16%, more preferably 2 to 10%. The soy milk may be heat sterilized prior to the fermentation treatment.
[0014] Examples of lactic acid bacteria include lactic acid bacteria belonging to any of the genera Lactobacillus, Streptococcus, Enterococcus, Lactococcus, and Bifidobacterium. As the lactic acid bacteria, one or more types of lactic acid bacteria selected from the group consisting of lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Streptococcus, lactic acid bacteria belonging to the genus Enterococcus, lactic acid bacteria belonging to the genus Lactococcus, and lactic acid bacteria belonging to the genus Bifidobacterium are preferred. Among these, a combination containing at least lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Enterococcus is preferred, A combination containing at least lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Enterococcus, and lactic acid bacteria belonging to the genus Bifidobacterium is more preferable, More preferably, the combination includes at least lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Streptococcus, lactic acid bacteria belonging to the genus Enterococcus, and lactic acid bacteria belonging to the genus Bifidobacterium. A combination containing at least lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Streptococcus, lactic acid bacteria belonging to the genus Enterococcus, lactic acid bacteria belonging to the genus Lactococcus, and lactic acid bacteria belonging to the genus Bifidobacterium is particularly preferred. When using two or more types of lactic acid bacteria, it is preferable to use a culture obtained by co-cultivating two or more types of lactic acid bacteria that are capable of coexisting with each other.
[0015] Examples of lactic acid bacteria belonging to the genus Lactobacillus include Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus jensenii, Lactobacillus paracasei subsp. paracasei, Lactobacillus gasseri, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus helveticus, Lactobacillus casei subsp. casei, Lactobacillus rhamnosus, Lactobacillus delbrueckii subsp. delbrueckii, and the like.
[0016] Examples of lactic acid bacteria belonging to the genus Streptococcus include S. thermophilus, etc. Examples of lactic acid bacteria belonging to the genus Enterococcus include E. faecium, etc. Examples of lactic acid bacteria belonging to the genus Lactococcus include L. lactis, etc. Examples of lactic acid bacteria belonging to the genus Bifidobacterium include B. longum, B. bifidum, B. adolescentis, etc.
[0017] Specific examples of the above-mentioned lactic acid bacteria strains include JCM1021 strain, JCM1023 strain, JCM1028 strain, JCM1033 strain, JCM1034 strain, JCM1132 strain, JCM1061 strain, JCM1065 strain, JCM11034 strain, JCM11035 strain, JCM1053 strain, JCM1109 strain, JCM1111 strain, JCM1133 strain, JCM1017 strain, JCM1019 strain, JCM1025 strain, JCM1131 strain, JCM1002 strain, Examples of such strains include JCM11037, JCM11038, JCM1003, JCM1004, JCM1120, JCM1134, JCM1136, JCM1165, JCM1553, JCM20075, JCM20088, JCM17834, JCM20026, JCM5804, JCM5805, JCM1217, JCM7052, JCM1254, JCM1255, JCM1275, and KOEI.
[0018] Lactic acid bacteria may be used alone or in combination of two or more symbiotic species, but it is preferable to use a combination of 5 to 50 species, more preferably a combination of 10 to 45 species, and particularly preferably a combination of 15 to 40 species. Different strains of the same genus may also be combined.
[0019] When the lactic acid fermentation treatment of soy milk is carried out using a symbiotic culture of lactic acid bacteria, the symbiotic culture of lactic acid bacteria carried out prior to the fermentation treatment and the fermentation treatment using the obtained symbiotic culture can be carried out with reference to the descriptions in, for example, JP 2005-97280 A, JP 2016-202139 A, and Japanese Patent No. 4,540,376.
[0020] Here, the co-culture of lactic acid bacteria will be described. The co-cultivation is preferably carried out by a method including a primary culture step of co-cultivating two or more kinds of lactic acid bacteria. More specifically, the method includes a preliminary culture step of preparing k groups consisting of one or two or more kinds of lactic acid bacteria, from the first group to the kth group (k is an integer of 2 or more, preferably an integer of 6 to 48, more preferably an integer of 12 to 36, and particularly preferably 24), culturing each group, and obtaining a total of k lactic acid bacteria cultures from the first lactic acid bacteria culture to the kth lactic acid bacteria culture, and a primary culture step of co-cultivating k / 2 lactic acid bacteria mixtures for primary culture (e.g., 12 when k=24) by mixing two lactic acid bacteria cultures of adjacent numbers in order from the first lactic acid bacteria culture to the kth lactic acid bacteria culture.
[0021] For each of the first to kth groups, one or more species of lactic acid bacteria that can coexist during primary culture may be selected. When two or more species of lactic acid bacteria are included in one group, the selection may be made so that the symbiotic state of the two or more species of lactic acid bacteria is maintained even when subcultured in the preliminary culture step. The term "maintaining a symbiotic state" refers to the simultaneous presence of two or more species of lactic acid bacteria, each of which maintains its activity. The same species of lactic acid bacteria may be included in different groups.
[0022] For example, when k=24, the combination of lactic acid bacteria from the first group to the kth group is as follows: The first to fourth groups are groups each composed of a combination of lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Enterococcus, Of the fifth to eighth groups, two groups are composed of a combination of lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Enterococcus, and the remaining two groups are composed only of lactic acid bacteria belonging to the genus Bifidobacterium and only of lactic acid bacteria belonging to the genus Lactobacillus, Among the 9th to 12th groups, two groups are composed of a combination of lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Enterococcus, and the remaining two groups are both composed only of lactic acid bacteria belonging to the genus Lactobacillus, Of the 13th to 16th groups, two are composed only of lactic acid bacteria belonging to the Lactobacillus genus, and the remaining two groups are a group composed of a combination of lactic acid bacteria belonging to the Lactobacillus genus, lactic acid bacteria belonging to the Enterococcus genus, and lactic acid bacteria belonging to the Bifidobacterium genus, and a group composed of a combination of lactic acid bacteria belonging to the Streptococcus genus, lactic acid bacteria belonging to the Enterococcus genus, and lactic acid bacteria belonging to the Bifidobacterium genus, Among the 17th to 20th groups, two groups are groups consisting of a combination of lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Streptococcus, and the remaining two groups are a group consisting of a combination of lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Enterococcus, and lactic acid bacteria belonging to the genus Lactococcus, and a group consisting of only lactic acid bacteria belonging to the genus Lactococcus, Of the 21st to 24th groups, two are composed only of lactic acid bacteria belonging to the genus Lactobacillus, one is composed only of lactic acid bacteria belonging to the genus Bifidobacterium, and the remaining group is a combination of lactic acid bacteria belonging to the genus Lactobacillus and lactic acid bacteria belonging to the genus Enterococcus.
[0023] The pre-culture step and the primary culture step may be performed under aerobic or anaerobic conditions, but it is preferable to perform static culture under aerobic conditions. The medium used for the culture may be selected according to the type of lactic acid bacteria, but an agar-containing medium is preferable. Examples of commercially available products include GAM semi-fluid high-layer medium manufactured by Nissui Pharmaceutical Co., Ltd., BL agar medium manufactured by Nissui Pharmaceutical Co., Ltd., and modified GAM agar medium manufactured by Nissui Pharmaceutical Co., Ltd. The amount of lactic acid bacteria added in the preliminary culture step and the primary culture step is preferably 1 to 10% (w / w) per species of lactic acid bacteria relative to the medium. The culture temperature in each of the preliminary culture step and the primary culture step is usually 30 to 45° C., and the culture time is usually 3 to 72 hours. However, the primary culture step is preferably carried out until the pH reaches a range of 4.4 to 4.8.
[0024] Next, the lactic acid bacteria fermentation treatment of soy milk will be described in detail. Methods for inoculating soy milk with lactic acid bacteria include, for example, a method of adding lactic acid bacteria to soy milk and allowing it to stand, a method of mixing soy milk with lactic acid bacteria, a method of contacting soy milk with a culture solution in which lactic acid bacteria have been cultured in an appropriate medium, and a method of culturing lactic acid bacteria in an appropriate medium to which soy milk has been added.
[0025] As the lactic acid bacteria fermentation treatment of soy milk, a symbiotic fermentation treatment with two or more kinds of lactic acid bacteria (specifically, a fermentation treatment using a symbiotic culture obtained by symbiotic culture of the above-mentioned lactic acid bacteria) is preferable. Here, when the above-mentioned primary culture step is performed in which adjacent lactic acid bacteria cultures of the first to kth lactic acid bacteria cultures are mixed in pairs to obtain k / 2 lactic acid bacteria mixtures for primary culture, and each of these is co-cultured, it is preferable to combine adjacent primary cultures in pairs in the order of the first primary culture containing the lactic acid bacteria of the first and second groups to the k / 2 primary culture containing the lactic acid bacteria of the k-1 and k groups (for example, the 23rd and 24th groups when k=24), and to incorporate this combination into soy milk for fermentation treatment (secondary culture). Furthermore, when carrying out the above-mentioned secondary culture, it is preferable to combine all of the k / 4 (e.g., 6 when k=24) secondary culture products obtained in the secondary culture, add them to soy milk, and further carry out fermentation treatment (tertiary culture).
[0026] The secondary and tertiary cultures may be performed under aerobic or anaerobic conditions, but are preferably statically cultured under aerobic conditions. In either the secondary culture or the tertiary culture, the soy milk may contain, if necessary, sugars such as glucose and the like; nitrogen sources such as yeast extract and peptone; and the like. In the secondary culture, each primary culture can be added together with the medium to the soy milk. The amount of the primary culture added is preferably 1 to 10% (w / w) for each type of primary culture relative to the soy milk. In the tertiary culture, each secondary culture can be added together with the medium to the soy milk. The amount of the secondary culture added is preferably 1 to 10% (w / w) for each type of secondary culture relative to the soy milk.
[0027] The culture temperature for the secondary culture is usually 30 to 45° C., and the culture time is usually 3 to 48 hours, but the secondary culture step is preferably carried out until the pH reaches the range of 4.4 to 4.8. The culture temperature for the tertiary culture is usually 30 to 45° C., and the culture time is usually 10 hours to 1 week, but it is preferable to culture by changing the temperature in three stages. Specifically, the method includes culturing at 30 to 37° C. for 12 to 36 hours, culturing at 38 to 45° C. for 24 to 72 hours, and further culturing at 30 to 37° C. for 12 to 96 hours.
[0028] Furthermore, the lactic acid bacteria fermentation product of soy milk obtained as described above can be used as an aquaporin expression promoter or a keratinization marker expression promoter as it is, but it may also be used after having been subjected to an appropriate selection of procedures as necessary, such as sterilization (for example, heat sterilization at 60 to 90°C for 15 to 60 minutes), removal of insoluble matter by centrifugation and recovery of the supernatant, removal of bacterial cells and recovery of the filtrate by filtration, drying treatment such as freeze-drying or spray-drying, recovery of lipids by lipid extraction, chromatography, etc.
[0029] As shown in the examples below, the lactic acid bacteria fermentation product of soy milk, trilinolein, has an excellent aquaporin expression promoting effect. Examples of aquaporins include one or more aquaporins selected from aquaporin 1, aquaporin 3, aquaporin 4, aquaporin 5, aquaporin 6, aquaporin 8, aquaporin 9, aquaporin 10, and aquaporin 11. Among the above active ingredients, the lactic acid bacteria fermentation product of soy milk is also excellent in the effect of promoting the expression of one or more aquaporins selected from aquaporin 4, aquaporin 5, aquaporin 6, and aquaporin 8, and can promote the expression of a wide variety of aquaporins. Therefore, the lactic acid bacteria fermentation product of soy milk, trilinolein, can promote the expression of aquaporins present in the body, such as in the oral cavity, nasal mucosa, eyes, kidneys, lungs, large intestine, small intestine, and brain, in addition to the skin, and is particularly useful for maintaining and strengthening skin moisture. In addition, the lactic acid bacteria fermentation product of soy milk, trilinolein, can be an aquaporin expression promoter and can be used to promote aquaporin expression. The aquaporin expression promoter can be used as a medicine, cosmetic, or food that is effective in promoting aquaporin expression, or as a material to be added to a medicine, cosmetic, or food.
[0030] Furthermore, as shown in the examples below, the lactic acid bacteria fermentation product of soy milk, trilinolein, has an excellent effect of promoting the expression of keratinization markers and is more suitable for promoting the expression of one or more keratinization markers selected from filaggrin, involucrin, loricrin, transglutaminase and keratin, and is particularly suitable for promoting the expression of one or more keratinization markers selected from filaggrin, involucrin, loricrin, transglutaminase-1, transglutaminase-3, keratin-1 and keratin-10. Therefore, the lactic acid bacteria fermented soy milk, trilinolein, can promote the expression of keratinization markers present in the body, such as the skin, and is useful for regulating epidermal keratinization and maintaining and strengthening the skin defense function. In addition, the lactic acid bacteria fermented soy milk, trilinolein, can be a keratinization marker expression promoter and can be used to promote keratinization marker expression. The keratinization marker expression promoter can be used as a medicine, cosmetic, or food that is effective in promoting keratinization marker expression, or as a material to be added to a medicine, cosmetic, or food.
[0031] The food may be a health functional food, such as a functional food, a food for specified health use, or a food with nutritional function claims, based on the concept of promoting aquaporin expression or keratinization marker expression. Specific forms include soft drinks, capsules, tablets, jellies, granules, bread, noodles, confectionery, seasonings, etc., for the purpose of maintaining or enhancing skin moisture, and may also be used as a material to be added to supplements or foods in the form of liquid or powder. For patients with senile xerosis or atopic dermatitis who wish to enhance skin moisture, it may be a supplementary food to improve symptoms.
[0032] The means of application of the aquaporin expression promoter and the keratinization marker expression promoter of the present invention may be any of oral administration, injection, topical application to the skin, etc., but oral administration or topical application to the skin is preferred, and topical application to the skin is more preferred. When the aquaporin expression promoter and keratinization marker expression promoter of the present invention are orally administered, their dosage forms include solid preparations such as tablets, granules, and capsules; semi-solid preparations; and liquid preparations. In both the case of pharmaceuticals and foods, these dosage forms may be used. Furthermore, when the composition is orally administered, additives such as excipients, disintegrants, binders, and lubricants may be contained in addition to the above-mentioned active ingredients. When the aquaporin expression promoter and keratinization marker expression promoter of the present invention are used as external preparations for the skin, their dosage forms include ointments, creams, milky lotions, gels, pastes, lotions, etc. When used as external preparations for the skin, in addition to the above-mentioned active ingredients, various ingredients used as base materials or additives in ordinary external preparations can be contained. For example, solid, semi-solid or liquid oils such as natural animal and vegetable oils, semi-synthetic oils, hydrocarbon oils, higher fatty acids, higher alcohols, ester oils, silicone oils, and fluorine-based oils; water; alcohols such as lower alcohols, sugar alcohols, and sterols; plant-based polymers such as gum arabic and tragacanth; microbial polymers such as xanthan gum and dextran; starch-based polymers such as carboxymethyl starch; cellulose-based polymers such as sodium carboxymethyl cellulose; surfactants such as various anionic, cationic, nonionic, and amphoteric surfactants; oil-soluble gelling agents such as metal soaps, dextrin fatty acid esters, and sucrose fatty acid esters; inorganic powders such as titanium oxide, magnesium carbonate, mica, and hydroxyapatite; organic powders such as polyamide powder; colored pigments; pearl pigments; moisturizers; preservatives; pH adjusters; chelating agents; cooling agents; anti-inflammatory agents; and skin-beautifying ingredients such as whitening agents, cell activators, and blood circulation promoters.
[0033] In the aquaporin expression promoter of the present invention, the content of one or more selected from lactic acid bacteria fermentation product of soy milk and trilinolein is preferably 0.1 to 80 mass %, more preferably 0.1 to 50 mass %, and particularly preferably 0.1 to 30 mass %. In the cornification marker expression promoter of the present invention, the content of one or more selected from a lactic acid bacteria fermentation product of soy milk and trilinolein is preferably 0.1 to 80 mass %, more preferably 0.1 to 50 mass %, and particularly preferably 0.1 to 30 mass %.
[0034] The aquaporin expression promoter of the present invention is preferably ingested or applied in an amount of 10 mg to 5 g per day for an adult as one or more selected from a lactic acid bacteria fermentation product of soy milk and trilinolein. The cornification marker expression promoter of the present invention is preferably ingested or applied in an amount of 10 mg to 5 g per day for an adult as one or more selected from a lactic acid bacteria fermentation product of soy milk and trilinolein. EXAMPLES
[0035] The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples.
[0036] [Preparation Example 1] Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus jensenii, Lactobacillus paracasei subsp. paracasei, Lactobacillus gasseri, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus helveticus, Lactobacillus casei subsp. casei, Lactobacillus rhamnosus, Lactobacillus delbrueckii subsp. delbrueckii, Streptococcus thermophilus, Enterococcus faecium Commercially available food products of 16 types of lactic acid bacteria, namely Lactococcus faecium, Lactococcus lactis, Bifidobacterium longum, Bifidobacterium bifidum, and Bifidobacterium adolescentis, were prepared, and 24 groups, No. 1 to No. 24, were prepared from these 16 types of lactic acid bacteria as shown in FIG. 1. The species of each group were subcultured, and then primary to tertiary cultures were performed, and the final culture solution was sterilized to prepare a lactic acid bacteria fermentation product of soy milk. This fermentation product is also referred to as "lactic acid bacteria production material 1". The specific procedure is shown below. Note that FIG. 1 is a diagram showing each process from the group creation process to the tertiary culture process. Also, "No." in FIG. 1 is the group number.
[0037] Group No. 1: E. faecium and L. helveticus Group No. 2: E. faecium and L. acidophilus Group No. 3: E. faecium and L. gasseri Group No. 4: E. faecium, L. acidophilus and L. brevis
[0038] Group No. 5: E. faecium, L. acidophilus and L. brevis Group No. 6: E. faecium, L. acidophilus, L. brevis and L. paracasei Group No.7: B. Adolescentis alone Group No.8: L. Delbricky and L. Gassery
[0039] Group No. 9: L. Delbricky alone Group No. 10: E. faecium, L. jensenii, L. paracasei and L. brevis Group No. 11: L. acidophilus alone Group No. 12: E. faecium and L. gasseri
[0040] Group No. 13: L. paracasei alone Group No. 14: L. gasseri, E. faecium and B. bifidum Group No. 15: B. longum, S. thermophilus and E. faecium Group No. 16: L. Gasseri alone
[0041] Group No. 17: L. bulgaricus and S. thermophilus Group No. 18: L. gasseri, L. lactis and E. faecium Group No. 19: L. gasseri, S. thermophilus and L. bulgaricus Group No. 20: L. lactis alone
[0042] Group No. 21: L. gasseri and E. faecium Group No. 22: L. lamonausus alone Group No. 23: L. casei alone Group No. 24: B. longum alone
[0043] (Subculture) One loopful of each lactic acid bacteria from Group No. 1 was inoculated into 10 mL of medium and cultured at 32°C for 12 hours. The bacteria were then subcultured and cultured at 37°C for 12 hours, and then subcultured again and cultured at 40°C for 24 hours. The culture solution was then refrigerated and stored at 5°C. Furthermore, the lactic acid bacteria of groups No. 2 to No. 24 were subcultured in the same manner as above. The media used were three types depending on the lactic acid bacteria in each group: GAM semi-fluid high layer medium (Nissui Pharmaceutical Co., Ltd.), BL agar medium (Nissui Pharmaceutical Co., Ltd.), and modified GAM agar medium (Nissui Pharmaceutical Co., Ltd.).
[0044] An identification test was conducted on the culture fluid of each group obtained by subculturing in this way. The identification test was outsourced to the Japan Food Research Laboratories. That is, samples from each group were directly inoculated and cultured on an agar plate medium, and the predominantly grown colonies with different shapes were picked up to isolate lactic acid bacteria from each group. The isolated bacteria were then subjected to morphological observation, physiological property tests, and measurement of the GC content of intracellular DNA, and identification was performed with reference to the following literature. As a result of the identification, a total of 34 strains were identified in addition to B. longum, and it was confirmed that they maintained a symbiotic state within each group.
[0045] 1.Sneath,PHA, Mair,NS, Sharpe,ME and Holt,JG: "Bergey's Manual of Systematic Bacteriology" Vol.2, (1986) Williams & Wilkins. 2. Holt, JG, Krieg, NR, Sneath, PHA, Staley, JT and Williams, ST: "Bergey's Manual of Determinative Bacteriology" Ninth Edition (1994) Williams & Wilkins. 3. Tomotari Mitsuoka: “The World of Intestinal Bacteria”, (1984) Sobunsha. 4. Yoshimi Benno: Microorganisms 6, 3-14 (1990). 5. Supervised by the Ministry of Health, Labor and Welfare, Bureau of Environmental Health: “Food Hygiene Inspection Guidelines - Microorganisms” (1990) Japan Food Sanitation Association. 6.Schleifer, KH and Kilpper-Balz, R.: Int.J.Syst.Bacteriol.,34,31-34(1984).
[0046] (Primary culture) Next, co-culture of the primary cultures (1) to (12) shown in FIG. 1 was carried out. That is, the culture medium obtained by the above subculture was added to 50 mL of the primary culture medium under the conditions shown in Table 1, and cultured at 37° C. for about 6 to 12 hours until the pH value of the primary culture medium reached 4.6. Three types of media were used for the primary culture: GAM semi-fluid high layer medium (manufactured by Nissui Pharmaceutical Co., Ltd.), BL agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.), and modified GAM agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.), depending on the lactic acid bacteria contained in the culture solution obtained by subculture.
[0047] [Table 1]
[0048] (Secondary culture) Next, co-culture of the secondary cultures (13) to (18) shown in FIG. 1 was carried out. That is, a secondary culture medium was prepared by adding 0.5% (w / w) glucose and 0.4% (w / w) yeast extract to 1,600 mL of soy milk, and the lactic acid bacteria that had completed the above primary culture process were added to this secondary culture medium together with the primary culture medium under the conditions shown in Table 2, and cultured at 37°C for approximately 6 to 10 hours until the pH value reached 4.55.
[0049] [Table 2]
[0050] (tertiary culture) Next, the tertiary culture (19) shown in Figure 1 was co-cultured. That is, 0.5% (w / w) glucose and 0.4% (w / w) yeast extract were added to 1000 L of soy milk to prepare a tertiary culture medium, and all the lactic acid bacteria that had completed the secondary culture process were added to this tertiary culture medium together with the secondary culture medium. Note that approximately 1720 mL of the culture liquid obtained in the secondary cultures (13) to (18) was used. The cells were then cultured at 32°C for 24 hours, then at 40°C for 48 hours, and finally at 37°C for 48 hours. The final culture solution containing the lactic acid bacteria and the medium obtained in the above tertiary culture process was sterilized by heating at 85° C. or higher for 15 minutes to obtain lactic acid bacteria production substance 1 (yogurt-like substance).
[0051] [Preparation Example 2] The lactic acid bacteria production substance 1 obtained in Preparation Example 1 was centrifuged (10,000 rpm, 4° C., 10 minutes) and the resulting supernatant (light yellow liquid, pH = about 3.8) was collected. This supernatant is also referred to as "lactic acid bacteria production substance 2."
[0052] [Preparation Example 3] The lactic acid bacteria production substance 1 obtained in Preparation Example 1 was freeze-dried and powdered. 15 g of this frozen powder was suspended in 200 mL of diethyl ether, ultrasonicated for 20 minutes, and filtered (ADVANTEC 5C, 150 mm) to collect the filtrate. The residue generated by filtration was treated in the same manner as above, and this filtrate was combined with the above filtrate and concentrated in a rotary evaporator to obtain lipids. The yield was 2.7 g. Next, 1.5 g of the obtained lipid was fractionated by open column chromatography under the following conditions: The developing solution was divided into fractions of 12 mL each, and the first fraction was named "fraction 1" and the second fraction was named "fraction 2." (Fraction conditions) Column container: AS ONE chromatographic tube (inner diameter 3 cm) Carrier: Wakogel 60N, 63-212μm (filling height 20cm) Developing solvent: 600 mL of a mixture of 95 parts by weight of hexane and 5 parts by weight of ethanol
[0053] [Test Example 1-1] Add 0.8 mL of medium (HuMedia-KG2) to one well of a 12-well plate, and then inoculate 5 × 10 normal human epidermal keratinocytes (derived from newborns). 5 After seeding, the cells were cultured for 3 days (37°C, 95% air, 5% CO2) until they reached 70-80% confluence. Then, 0.1% (w / w) of lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, or fraction 2 was added and cultured. The culture time for the medium containing lactic acid bacteria production substance 1 was 72 hours, the culture time for the medium containing lactic acid bacteria production substance 2 was 48 hours, the culture time for the medium containing fraction 1 was 72 hours, and the culture time for the medium containing fraction 2 was 24 hours. The supernatant was then discarded, and the cells were completely lysed. Total RNA was extracted, reverse transcribed to prepare cDNA, and the gene expression level of aquaporin-1 was detected by quantitative real-time PCR (n=5). The results are shown in Figures 2-1 to 2-4 (note that the control in each figure is a group to which no sample was added).
[0054] [Test Example 1-2] The expression level of aquaporin-10 gene when lactic acid bacteria production substance 2 or fraction 1 was added at 0.5% (w / w) and cultured for 24 hours or 72 hours was detected according to the method described in Test Example 1-1 (n=5). The results are shown in Figures 3-1 and 3-2 (note that the control in each figure is a group to which no sample was added). The expression level of aquaporin-11 gene when lactic acid bacteria production substance 2 or fraction 1 was added at 0.1% (w / w) and cultured for 72 hours was detected according to the method described in Test Example 1-1 (n=5). The results are shown in Figures 4-1 and 4-2 (note that the control in each figure is a group to which no sample was added).
[0055] [Test Example 1-3] Add 0.8 mL of medium (HuMedia-KG2) to one well of a 12-well plate, and then inoculate 5 × 10 normal human epidermal keratinocytes (derived from newborns). 5After seeding, the cells were cultured for 3 days (37°C, 95% air, 5% CO2) until the cells reached 70-80% confluence. Lactic acid bacteria production substance 1, fraction 1, or trilinolein (standard product from Tokyo Chemical Industry Co., Ltd.) was then added at 0.02% (w / w), 0.1% (w / w), or 0.5% (w / w) and cultured for 72 hours. The supernatant was then discarded and the cells were completely lysed. Proteins were denatured at 100°C, then electrophoresed on a polyacrylamide gel to separate the proteins, which were then transferred to a membrane. After blocking with Immunoblock (KAC), the primary antibody (rabbit anti-aquaporin 1) was added and incubated overnight at 4°C. After washing, the secondary antibody (goat anti-rabbit IgG) was added and incubated at room temperature for 1 hour. After washing, a luminescent and chromogenic substrate (Luminata Forte (Merck)) was added and incubated, and the signal was detected using a chemiluminescence detection device (Fujifilm LAS400). The uniform loading of the sample onto the polyacrylamide gel was verified in a similar experiment using anti-β-actin antibody as the primary antibody. The expression level of aquaporin-1 was then quantified using Fujifilm's LAS400. The measurement results of the expression level of aquaporin-1 are shown in Figures 5-1 and 5-2. In addition, LABM1 in Figure 5-2 means lactic acid bacteria production substance 1 (the same applies below).
[0056] [Test Example 1-4] Lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, fraction 2, or trilinolein (standard product from Tokyo Chemical Industry Co., Ltd.) was added and cultured for 48 or 72 hours, and the expression level of aquaporin-3 was measured and quantified according to the method described in Test Example 1-3. Rabbit anti-aquaporin 3 was used as the primary antibody. The results of measuring the expression level of aquaporin-3 are shown in Figures 5-3 and 5-4.
[0057] [Test Example 1-5] Fraction 1 was added and cultured for 72 hours, and the expression level of aquaporin-4 was measured according to the method described in Test Example 1-3. Mouse anti-aquaporin 4 was used as the primary antibody. The results of measuring the expression level of aquaporin-4 are shown in FIG.
[0058] [Test Example 1-6] The expression level of aquaporin-5 after 24 hours of culture with lactic acid bacteria production substance 2 was measured and quantified according to the method described in Test Example 1-3. Rabbit anti-aquaporin 5 was used as the primary antibody. The measurement results of the expression level of aquaporin-5 are shown in Figures 5-6 and 5-7. In addition, LABM2 in Figure 5-7 means lactic acid bacteria production substance 2 (the same applies below).
[0059] [Test Example 1-7] The expression level of aquaporin-6 when cultured for 72 hours with lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, or fraction 2 was measured and quantified according to the method described in Test Example 1-3. Rabbit anti-aquaporin 6 was used as the primary antibody. The measurement results of aquaporin-6 expression levels are shown in Figures 5-8 and 5-9.
[0060] [Test Example 1-8] Fraction 2 was added and cultured for 72 hours, and the expression level of aquaporin-8 was measured according to the method described in Test Example 1-3. Note that rabbit anti-aquaporin 8 was used as the primary antibody. The results of measuring the expression level of aquaporin-8 are shown in Figure 5-10.
[0061] [Test Example 1-9] The expression level of aquaporin-9 after culturing for 24 or 48 hours with lactic acid bacteria production substance 1, fraction 1, fraction 2, or trilinolein (standard product manufactured by Tokyo Chemical Industry Co., Ltd.) was measured and quantified according to the method described in Test Example 1-3. Rabbit anti-aquaporin 9 was used as the primary antibody. The results of measuring the expression level of aquaporin-9 are shown in Figures 5-11 and 5-12.
[0062] [Test Example 1-10] The expression level of aquaporin-10 after culturing for 72 hours with lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1 or trilinolein (standard product manufactured by Tokyo Chemical Industry Co., Ltd.) was measured and quantified according to the method described in Test Example 1-3. Rabbit anti-aquaporin 10 was used as the primary antibody. The results of measuring the expression level of aquaporin-10 are shown in Figures 5-13 and 5-14.
[0063] As shown in Figures 2-1 to 5-14, it was found that the lactic acid bacteria fermentation products of soy milk (lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, fraction 2) and trilinolein have excellent aquaporin expression promoting effects. In particular, the lactic acid bacteria fermentation products of soy milk promoted the expression of a wide variety of aquaporins.
[0064] [Test Example 2] Add 0.8 mL of medium (HuMedia-KG2) to one well of a 12-well plate, and then inoculate 5 × 10 normal human epidermal keratinocytes (derived from newborns). 5 After seeding, the cells were cultured for 3 days (37°C, 95% air, 5% CO2) until they reached 70-80% confluence. Then, lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, fraction 2, or trilinolein (standard product manufactured by Tokyo Chemical Industry Co., Ltd.) was added at 0.02% (w / w), 0.1% (w / w), or 0.5% (w / w) and cultured for 48 hours or 72 hours. Then, the supernatant was discarded and the cells were completely dissolved. Total RNA was extracted, and cDNA was prepared by reverse transcription of the RNA, and the gene expression levels of filaggrin, involucrin, loricrin, transglutaminase-1, transglutaminase-3, keratin-1, and keratin-10 were detected by quantitative real-time PCR (n=5). The results are shown in Figures 6-1 to 10-2 (note that the control in each figure is a group to which no sample was added).
[0065] As shown in Figures 6-1 to 10-2, lactic acid bacteria production substance 1, lactic acid bacteria production substance 2, fraction 1, fraction 2 and trilinolein promoted the expression of filaggrin, involucrin, loricrin, transglutaminase-1, transglutaminase-3, keratin-1 and keratin-10. The results in Figs. 6-1 to 10-2 demonstrate that trilinolein, a lactic acid bacteria fermentation product of soy milk, has an excellent effect of promoting the expression of keratinization markers.
Claims
1. An aquaporin expression promoter comprising one or more active ingredients selected from the following ingredients (A) and (B), in which ingredient (A) is a lipid component recovered by subjecting soy milk to lactic acid fermentation treatment and subjecting the treated product obtained by said treatment to lipid extraction, and the lactic acid bacteria is a combination including at least lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Streptococcus, lactic acid bacteria belonging to the genus Enterococcus, lactic acid bacteria belonging to the genus Lactococcus, and lactic acid bacteria belonging to the genus Bifidobacterium. (A) Lactic acid bacteria fermented soy milk (B) Trilinolein
2. The aquaporin expression promoter according to claim 1 , wherein the aquaporin is one or more aquaporins selected from aquaporin 1, aquaporin 3, aquaporin 4, aquaporin 5, aquaporin 6, aquaporin 8, aquaporin 9, aquaporin 10 and aquaporin 11.
3. The aquaporin expression promoter according to claim 1, wherein the active ingredient is a lactic acid bacteria fermentation product of soy milk, and the aquaporin is one or more types of aquaporin selected from aquaporin 4, aquaporin 5, aquaporin 6 and aquaporin 8.
4. An aquaporin expression promoter as described in claim 1 (excluding the case where the active ingredient is an extract of lactic acid bacteria fermentation product of soy milk using a polar solvent that is miscible with water).
5. An aquaporin expression promoter having trilinolein as an active ingredient.
6. A keratinization marker expression promoter comprising one or more active ingredients selected from the following components (A) and (B), in which component (A) is a lipid component recovered by subjecting soy milk to lactic acid fermentation treatment and subjecting the treated product obtained by said treatment to lipid extraction, and the lactic acid bacteria is a combination including at least lactic acid bacteria belonging to the genus Lactobacillus, lactic acid bacteria belonging to the genus Streptococcus, lactic acid bacteria belonging to the genus Enterococcus, lactic acid bacteria belonging to the genus Lactococcus, and lactic acid bacteria belonging to the genus Bifidobacterium. (A) Lactic acid bacteria fermented soy milk (B) Trilinolein
7. The cornification marker expression promoter according to claim 6 , wherein the cornification marker is one or more cornification markers selected from filaggrin, involucrin, loricrin, transglutaminase and keratin.
8. A keratinization marker expression promoter as described in claim 6 (excluding the case where the active ingredient is an extract of a lactic acid bacteria fermentation product of soy milk using a polar solvent that is miscible with water).
9. A keratinization marker expression promoter having trilinolein as an active ingredient.
Citation Information
Patent Citations
Matrix metalloprotease-1(MMP-1) inhibitor, matrix metalloprotease-2(MMP-2) inhibitor, estrogen-like action agent, profilaggrin production promoter, filaggrin production promoter, antiobese agent and cyclic amp phosphodiesterase activity inhibitor
JP2009067749A
Profilaggrin and / or filaggrin production accelerator
JP2009256269A
Aquaporin production enhancing preparation
JP2013087057A
Aquaporin production enhancing preparation
JP2013087058A
Aquaporin production-enhancing preparation
JP2013095667A
